Showing results (11-20 of 50) with videos related to
Sort By:
Pageof 5
The Lancet. Infectious Diseases|May 1, 2012
Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccineJason Grebely, Maria Prins, Margaret Hellard, et al.The Journal of Infectious Diseases|April 6, 2005
Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategiesRajesh T Gandhi, Alysse Wurcel, Hang Lee, et al.Journal of Dental Education|January 11, 2015
The influence of examiner type on dental students' OSCE scoresSang E Park, Arthur Kim, Joshua Kristiansen, et al.Mucosal Immunology|March 10, 2016
Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16Bronwyn Gunn, Jeffrey Schneider, Maryam Shansab, et al.Journal of Virology|November 20, 2002
Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infectionCheryl L Day, Georg M Lauer, Gregory K Robbins, et al.Journal of Pediatric Hematology/Oncology|April 1, 2008
The prevalence of bleeding disorders among healthy pediatric patients with abnormal preprocedural coagulation studiesPeter H Shaw, Stacy Reynolds, Sriya Gunawardena, et al.AIDS (London, England)|July 19, 2023
Hepatitis B viral replication markers and hepatic fibrosis in untreated chronic hepatitis B virus infection with and without HIV coinfection in ZambiaGuy K Muula, Samuel Bosomprah, Edford Sinkala, et al.Biomarkers in Medicine|July 5, 2022
LOXL-2 and TNC-C are markers of liver fibrogenesis in HCV/HIV-, HIV- and HCV-infected patientsAkif Altinbas, Jacinta A Holmes, Shadi Salloum, et al.Frontiers in Medicine|May 16, 2018
Reactivation of a Vaccine Escape Hepatitis B Virus Mutant in a Cambodian Patient During Anti-Hepatitis C Virus TherapyDahlene N Fusco, Lilia Ganova-Raeva, Yury Khudyakov, et al.Hepatology (Baltimore, Md.)|November 14, 2025
The development of a pan-genotypic T cell vaccine against hepatitis C virus using heterologous prime-boost strategiesRebecca Strain, Matthew Edmans, Gerardo Montalvo Zurbia-Flores, et al.Pageof 5